Effect of Metformin Intervention during Pregnancy on the Gestational Diabetes Mellitus in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967 · see citing works

Polycystic Ovary Syndrome

Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,884 · see citing works

Metformin

Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726 · see citing works

Why we need observational studies to evaluate the effectiveness of health care

Black, N. (1996) · BMJ · doi:10.1136/bmj.312.7040.1215 · Cited by 1,598 · see citing works

Oral Antidiabetic Agents

Krentz, A. J., & Bailey, C. J. (2005) · Drugs · doi:10.2165/00003495-200565030-00005 · Cited by 1,132 · see citing works

Mechanism by which metformin reduces glucose production in type 2 diabetes.

Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052 · see citing works

Oral Antidiabetic Agents

Thomas, N., Senthil, K., & Kapoor, N. (2016) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/12651_7 · Cited by 943 · see citing works

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865 · see citing works

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

Boomsma, C. M., Eijkemans, M. J. C., Hughes, E. G., Visser, G. H. A., Fauser, B. C. J. M., & Macklon, N. S. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml036 · Cited by 852 · see citing works

Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome

Nestler, J. E., Jakubowicz, D. J., Evans, W. S., & Pasquali, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382603 · Cited by 781 · see citing works

Metformin Effects on Clinical Features, Endocrine and Metabolic Profiles, and Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled 6-Month Trial, followed by Open, Long-Term Clinical Evaluation¹

Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6293 · Cited by 660 · see citing works

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

Glueck, C. J., Phillips, H., Cameron, D., Sieve-Smith, L., & Wang, P. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01666-6 · Cited by 429 · see citing works

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

Glueck, C. J., Wang, P., Goldenberg, N., & Sieve-Smith, L. (2002) · Human Reproduction · doi:10.1093/humrep/17.11.2858 · Cited by 384 · see citing works

Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries.

Willis, D., Mason, H., Gilling-Smith, C., & Franks, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550768 · Cited by 371 · see citing works

Metformin Effects on Clinical Features, Endocrine and Metabolic Profiles, and Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled 6-Month Trial, followed by Open, Long-Term Clinical Evaluation

Moghetti, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.139 · Cited by 342 · see citing works

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

Glueck, C. J., Wang, P., Kobayashi, S., Phillips, H., & Sieve-Smith, L. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03202-2 · Cited by 325 · see citing works

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

Diamanti‐Kandarakis, E., Kouli, C., Tsianateli, T. C., & Bergiele, A. T. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380269 · Cited by 320 · see citing works

Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study

Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0853 · Cited by 315 · see citing works

Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study

Roos, N., Kieler, H., Sahlin, L., Ekman-Ordeberg, G. E., Falconer, H., & Stephansson, O. (2011) · BMJ · doi:10.1136/bmj.d6309 · Cited by 315 · see citing works

Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome

M, E., Acosta, A., & Mendoza, S. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00296-2 · Cited by 310 · see citing works

Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis

Kjerulff, L. E., Sanchez‐Ramos, L., & Duffy, D. A. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.03.021 · Cited by 299 · see citing works

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

Leo, V. D., Marca, A. L., & Petraglia, F. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0015 · Cited by 289 · see citing works

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome

Morin-Papunen, L. C., Koivunen, R. M., Ruokonen, A., & Martikainen, H. K. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00011-9 · Cited by 283 · see citing works

Randomized Clinical Trials and Observational Studies

Hannan, E. L. (2008) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.01.008 · Cited by 283 · see citing works

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

Koçak, M., Çalışkan, E., ŞİMŞİR, Ç., & Haberal, A. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02941-7 · Cited by 267 · see citing works

Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome

Harborne, L., Fleming, R., Lyall, H., Norman, J. E., & Sattar, N. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13493-9 · Cited by 256 · see citing works

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome

Velázquez-Maldonado, E., Mendoza, S. G., Wang, P., & Glueck, C. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90066-4 · Cited by 249 · see citing works

Placental passage of metformin in women with polycystic ovary syndrome

Vanky, E., Zahlsen, K., Spigset, O., & Carlsen, S. M. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.051 · Cited by 245 · see citing works

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.

Vanky, E., Salvesen, K., Heimstad, R., Fougner, K., Romundstad, P., & Carlsen, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh347 · Cited by 242 · see citing works

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome

Glueck, C. J., Wang, P., Fontaine, R. N., Tracy, T., & Sieve-Smith, L. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90113-0 · Cited by 228 · see citing works

Population pharmacokinetics of metformin in late pregnancy

Charles, B., Norris, R., Xiao, X., & Hague, W. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000184161.52573.0e · Cited by 212 · see citing works

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy

Glueck, C. J. (2004) · Human Reproduction · doi:10.1093/humrep/deh109 · Cited by 182 · see citing works

Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome

Glueck, C. J., Bornovali, S., Pranikoff, J., Goldenberg, N., Dharashivkar, S., & Wang, P. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01251.x · Cited by 115 · see citing works

Metformin for gestational diabetes in routine clinical practice

Goh, J. E. L., Sadler, L. C., & Rowan, J. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03361.x · Cited by 98 · see citing works

Nutrition, insulin and polycystic ovary syndrome

Franks, S. (1996) · Reviews of Reproduction · doi:10.1530/ror.0.0010047 · Cited by 98 · see citing works

Oral hypoglycemic agents: insulin secretagogues, α-glucosidase inhibitors and insulin sensitizers

Raptis, S. A., & Dimitriadis, G. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18588 · Cited by 97 · see citing works

Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?

Nawaz, F. H., Khalid, R., Naru, T. Y., & Rizvi, J. (2008) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2008.00856.x · Cited by 91 · see citing works

Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome

Glueck, C. J., Pranikoff, J., Aregawi, D., & Wang, P. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.03.036 · Cited by 81 · see citing works

Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome

Begum, M. R., Khanam, N. N., Quadir, E., Ferdous, J., Begum, M. S., Khan, F. I., & Begum, A. (2008) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2008.00876.x · Cited by 70 · see citing works

Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome

Checa, M. Á., Requena, A., Salvador, C., Tur, R., Callejo, J., Espinós, J. J., Fábregues, F., Herrero, J. C., & (Reproductive Endocrinology Interest Group of the Spanish Society of Fertility) (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi015 · Cited by 60 · see citing works

Metformin treatment in pregnant women with polycystic ovary syndrome–is reduced complication rate mediated by changes in the uteroplacental circulation?

Salvesen, K. Å., Vanky, E., & Carlsen, S. M. (2007) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.3965 · Cited by 48 · see citing works

Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double‐blind study

Fougner, K. J., Vanky, E., & Carlsen, S. M. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802254620 · Cited by 43 · see citing works

Continuation of Metformin Reduces Early Pregnancy Loss in Obese Pakistani Women with Polycystic Ovarian Syndrome

Nawaz, F. H., & Rizvi, J. (2009) · Gynecologic and Obstetric Investigation · doi:10.1159/000268051 · Cited by 43 · see citing works

On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome – an epi‐analysis

Vanky, E., de Zegher, F., Díaz, M., Ibáñez, L., & Carlsen, S. M. (2012) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12015 · Cited by 33 · see citing works

The Management of Polycystic Ovary Syndrome

Bruni, V., Dei, M., Pontello, V., & VANGELISTI, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.034 · Cited by 22 · see citing works

The role of continuing metformin therapy during pregnancy in the reduction of gestational diabetes and improving pregnancy outcomes in women with polycystic ovary syndrome

Hameed, A. A. A. E., Shreif, H. E., & Mowafy, H. E. M. (2011) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2011.04.002 · Cited by 20 · see citing works

Obstetrical care in gestational diabetes and management of preterm labour

Thiébaugeorges, O., & Guyard-Boileau, B. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.11.017 · Cited by 9 · see citing works

Diabetes and Pregnancy

Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344 · see citing works

The use of metformin in women with polycystic ovary syndrome: an updated review

Notaro, A. L. G., & Neto, F. T. L. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02429-9 · Cited by 83 · see citing works

Effect of metformin treatment during pregnancy on women with PCOS: a systematic review and meta-analysis

Tan, X., Li, S., Chang, Y., Fang, C., Liu, H., Zhang, X., & Wang, Y. (2016) · Clinical and Investigative Medicine · doi:10.25011/cim.v39i4.27091 · Cited by 51 · see citing works

Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials

Patel, R., & Shah, G. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1279597 · Cited by 47 · see citing works

Metformin therapy before conception versus throughout the pregnancy and risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systemic review, meta-analysis and meta-regression

Bidhendi Yarandi, R., Behboudi-Gandevani, S., Amiri, M., & Ramezani Tehrani, F. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0453-7 · Cited by 29 · see citing works

Metformin in pregnancy to avert gestational diabetes in women at high risk: Meta‐analysis of randomized controlled trials

Doi, S. A. R., Furuya‐Kanamori, L., Toft, E., Musa, O. A. H., Islam, N., Clark, J., & Thalib, L. (2020) · Obesity Reviews · doi:10.1111/obr.12964 · Cited by 39 · see citing works

From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management

Pani, A., Gironi, I., Di Vieste, G., Mion, E., Bertuzzi, F., & Pintaudi, B. (2020) · International Journal of Endocrinology · doi:10.1155/2020/6276187 · Cited by 38 · see citing works

당뇨를 동반한 4기 대장암 환자에서 항암약물요법 반응 및 생존율에 대한 Metformin의 효과

이동준, 김번, 이진하, et al. (2012)

Metformin for Prevention of Type 2 Diabetes

Hess, A. M., & Sullivan, D. L. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d537 · Cited by 11 · see citing works

A Rare Side Effect of Metformin: Metformin-Induced Hepatotoxicity

Aksay, E. (2007) · DergiPark (Istanbul University) · Cited by 15 · see citing works

Metformin-induced mitochondrial Complex I inhibition: facts, uncertainties, and consequences

Fontaine, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00753 · Cited by 269 · see citing works

Advances in the study on metformin beyond its hypoglycemic effect

Yang, D., & Ye, S. (2013) · International Journal of Pathology and Clinical Medicine